MENU
+Compare
TEVA
Stock ticker: NYSE
AS OF
Nov 21, 04:59 PM (EDT)
Price
$24.20
Change
-$0.08 (-0.33%)
Capitalization
28.35B

TEVA Teva Pharmaceutical Industries Limited Forecast, Technical & Fundamental Analysis

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world... Show more

TEVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TEVA with price predictions
Nov 20, 2025

TEVA in -2.25% downward trend, sliding for three consecutive days on November 20, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TEVA declined for three days, in of 317 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for TEVA moved out of overbought territory on November 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where TEVA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on November 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TEVA as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

TEVA broke above its upper Bollinger Band on November 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for TEVA just turned positive on October 30, 2025. Looking at past instances where TEVA's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

TEVA moved above its 50-day moving average on October 27, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TEVA advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 231 cases where TEVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TEVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.831) is normal, around the industry mean (17.079). P/E Ratio (39.689) is within average values for comparable stocks, (71.781). Projected Growth (PEG Ratio) (0.811) is also within normal values, averaging (1.902). TEVA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.665) is also within normal values, averaging (55.540).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
TEVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TEVA is expected to report earnings to fall 9.47% to 70 cents per share on February 11

Teva Pharmaceutical Industries Limited TEVA Stock Earnings Reports
Q4'25
Est.
$0.71
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.02
The last earnings report on November 05 showed earnings per share of 77 cents, beating the estimate of 68 cents. With 9.82M shares outstanding, the current market capitalization sits at 28.35B.
A.I.Advisor
published Dividends

TEVA paid dividends on December 12, 2017

Teva Pharmaceutical Industries Limited TEVA Stock Dividends
А dividend of $0.09 per share was paid with a record date of December 12, 2017, and an ex-dividend date of November 27, 2017. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
124 Dvora HaNevi’a Street
Phone
+972 39148213
Employees
37851
Web
https://www.tevapharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CCIF5.020.09
+1.83%
Carlyle Credit Income Fund
NBET32.790.24
+0.74%
Neuberger Berman Engy Trnstn & InfrasETF
GSY50.370.02
+0.04%
Invesco Ultra Short Duration ETF
DEFI95.56-2.11
-2.16%
Hashdex Bitcoin ETF
SPXS39.45-1.18
-2.90%
Direxion Daily S&P 500® Bear 3X ETF

TEVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
-0.29%
AMRX - TEVA
43%
Loosely correlated
+3.78%
VTRS - TEVA
33%
Poorly correlated
+2.75%
NBIX - TEVA
28%
Poorly correlated
+2.02%
BHC - TEVA
26%
Poorly correlated
+0.50%
SNDL - TEVA
26%
Poorly correlated
+1.26%
More

Groups containing TEVA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
-0.29%
Pharmaceuticals: Generic
industry (214 stocks)
36%
Loosely correlated
+1.55%